Boltz
Drug Discovery AI · Drug Discovery
13open roles
$97.4Mlatest round · Venture round · Oct 2026 · 1 mo ago
3backers · Andreessen Horowitz, Amplify Partners
200+team · employees, estimated range
Overview
Boltz is a public benefit company building AI-powered molecular modeling tools to make biology programmable and accelerate drug discovery. Its open models Boltz-1, Boltz-2 and BoltzGen are used by more than 100,000 scientists across biotech and academia. The company is headquartered in London, United Kingdom.
Key facts
As of Nov 13, 2026, Alion lists 13 open roles at Boltz. Boltz is headquartered in London, United Kingdom. It was founded in 2024. The latest round is Venture - Series Unknown of $97.4M, announced in 2026.
- Open roles
- 13Its careers board, read on Nov 13, 2026
- Headquarters
- London, United KingdomAlion company profile, updated Nov 13, 2026
- Founded
- 2024Alion company profile, updated Nov 13, 2026
- Employees
- 200+Alion company profile, an estimated range
- Total raised
- $97.4MSum of 1 equity round Alion knows
- Latest round
- Venture - Series Unknown · $97.4M · Oct 7, 2026SEC Form D filing · sec.gov
- Visa sponsorship, United Kingdom
- A-ratedUK Home Office · checked Nov 13, 2026
- Technologies in its job postings
- 24Named in its job postings
Official records
How Boltz hires
Truth index
D 40/100
Ghost roles
100%
Stale roles
0%
Reposted roles
0%
Boltz scores D on the Alion truth index (A is best, E worst), measured over 13 open roles re-checked against its own hiring board: 100% look like ghost listings, 0% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
Funding and backers
Total raised
$97.4M
1 round on record
Latest round
$97.4M
Venture round · Oct 2026 · 1 mo ago
Team
201-500
employees, estimated range
Hiring now
13
open roles
Backers
3
Andreessen Horowitz, Amplify Partners
The money's age
Fresh money
1 months since the last round · hiring slowed
Momentum
35/100
fresh money, rising traction
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 7
Raised a round Venture round $97.4M · SEC Form D
Jun 18
Partnership Boltz Announces Collaboration with Takeda to Deploy Frontier Biomolecular AI Models Across Takeda's Research Organization · morningstar.com
Aug 29, 2024
Founded per the company register
Tractionpublic signals, read monthly
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2026 | $97.4M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | BOLTZ LTD | Companies House |
| Registered | 29 Aug 2024 |
Founders and leadersfrom filings, registers and the company's site
Gabriele CorsoExecutive Officer, DirectorSEC Form D
Jeremy WohlwendExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Accelerate drug discovery with physics-based AI. Deep Origin combines simulations and machine learning to predict molecular properties and…
Novogaia is an applied AI drug discovery company that builds machine learning systems to decode the chemistry of natural organisms…
Latent Labs builds generative models that design proteins from a natural language description of the desired function. Founded in 2023 by a…
deepmirror is an AI-native drug design platform built around curated, non-public experimental molecule property measurements such as…
MOLCURE is an AI company that accelerates drug discovery by combining machine learning, biotechnology and robotics. Its antibody discovery…
Helical is the virtual AI lab for drug discovery. It turns your biology into a frontier discovery system on any model, ranks the candidates…
Jobs
≈ $73k – $177k per year (Estimated) · Equity · In office · Full-Time · London
Python
JavaScript
TypeScript
React.js
Apply
≈ $74k – $179k per year (Estimated) · Equity · In office · Full-Time · London
Python
TypeScript
PostgreSQL
AI/ML
Machine Learning
DevOps
AWS
Docker
Kubernetes
Apply
≈ $76k – $203k per year (Estimated) · Equity · In office · Full-Time · London
Python
SciPy
Pandas
NumPy
PyTorch
Machine Learning
Apply
≈ $123k – $247k per year (Estimated) · In office · Full-Time · London
Twilio
DevOps
AWS
Life Sciences
Benchling
Veeva
Apply
≈ $85k – $176k per year (Estimated) · In office · Full-Time · London
Weights & Biases
Hugging Face
Machine Learning
DevOps
Vercel
Apply
Apply
≈ $87k – $180k per year (Estimated) · Equity · Hybrid · Full-Time · 5+ years exp · PhD · London
Machine Learning
Apply
≈ $67k – $144k per year (Estimated) · In office · Full-Time · PhD · London
Python
Machine Learning
Life Sciences
Flow Cytometry
ELISA
Apply
≈ $51k – $95k per year (Estimated) · Hybrid · Full-Time · PhD · London
Python
Machine Learning
Apply
≈ $105k – $188k per year (Estimated) · Equity · In office · Full-Time · 5+ years exp · London
Python
PyTorch
Machine Learning
DevOps
CI/CD
Apply
≈ $63k – $144k per year (Estimated) · Equity · In office · Full-Time · London
Machine Learning
Design
Figma
Apply
≈ $87k – $205k per year (Estimated) · Equity · In office · Full-Time · PhD · London
Machine Learning
Apply
Visa sponsorship
A-rated
Sponsor licence
Skilled Worker
Visa route
13
Open roles in United Kingdom
In the register as Boltz Ltd, London
Other sponsors in the same field
Isomorphic Labs 
Relation Therapeutics
See 13 open roles Alert me
UK Home Office · checked Nov 13, 2026 · Visa details by country
Growth
Hiring Momentum
21/100
Hiring freeze
Open positions
13
0 opened / 0 closed in 30 days
Median time-to-fill
203 days
faster than 5% of the market
ATS activity
Every ~6 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
AI/ML
23% ▼
Biotech
23% ▼
Backend
15% ▼
Product
8% ▼
Communications
8% ▼
Design
8% ▼
Financials
Total raised
$97.4M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $97.4M | Details |
People
Gabriele Corso
Executive Officer, Director
Jeremy Wohlwend
Executive Officer, Director
Saro Passaro
Director
Sunil Dhaliwal
Director
Dylan Reid
Director
Andrew Hedin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Tech stack
Technologies named in job postings at Boltz over the last 12 months, by layer, with the share of postings for each.
Technologies in use
24
Postings analysed
13
Stack modernity
75/100
Languages
Python54%
TypeScript15%
JavaScript8%
Frameworks & libraries
PyTorch23%
NumPy15%
Pandas15%
SciPy15%
Databases
PostgreSQL8%
Cloud & platforms
AWS15%
Figma8%
GitHub8%
Kubernetes8%
Sign in to see how your skills match this stack
Sign In
Full Boltz tech stack
24 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Zetta Venture PartnersVia a fund
Amplify PartnersVia a fund
Andreessen HorowitzVia a fund
857 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
AI vs AI: How Boltz's Shutdown Reveals Bitcoin's New Threat Model
A swap provider pulled the plug on itself rather than keep fighting. The reason it gave wasn't a hack. It was a pace problem, and it says something bigger about where Bitcoin security is heading.
Read more
Report
Boltz Suspends Bitcoin Swaps amid Surge in AI-Assisted Attacks
Bitcoin swap service Boltz has suspended operations as AI-assisted attackers are finding and adapting exploits faster than its developers can patch them.
Read more
Report
Boltz Announces Collaboration with Takeda to Deploy Frontier Biomolecular AI Models Across Takeda's Research Organization
Read more
Report
From Sats To Stripe-Ready USDC: The Non-Custodial Bridge Everyone Was Waiting For
Boltz today enabled trustless Bitcoin-to-USDC swaps using Circle's CCTP, allowing instant movement between Bitcoin layers including Lightning and the regulated stablecoin accepted by Stripe, Coinbase, Visa, and global institutions - without accounts or cu
Read more
Report
Our Vision: The Future We Are Building at Boltz
We believe in a future where every scientist can iterate at the speed of inference. Our origin story, our mission as a public benefit corporation, and our three pillars: Research, Product, and Community.
Read more
Report
Announcing Boltz: A Public Benefit Corporation for AI-Driven Drug Discovery
We founded Boltz PBC to advance the frontier of AI in biology through open science. Announcing Boltz Lab, our first agents, a $28M seed round led by Amplify, a16z, and Zetta, and a partnership with Pfizer.
Read more
Report
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations but at speeds up to 1000x faster in standard benchmarks The deve
Read more
Report
Earn Bitcoin For Providing Liquidity Via Boltz Pro
I look forward to earning some sats in a non-custodial manner for helping Boltz manage its liquidity.
Read more
Report
Democratizing science with Boltz-1: the first truly open-source biomolecular structure prediction model - MIT Jameel Clinic
Read more
Report
MIT researchers introduce Boltz-1, a fully open-source model for predicting biomolecular structures
Researchers in the MIT Jameel Clinic for Machine Learning in Health developed a fully open-source biomolecular structure prediction model that achieves state-of-the-art performance, at the level of AlpahFold3, in an effort to democratize biomedical resear
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
London
London
United Kingdom
HQ
13 open roles 46% engineering 200-500 est. staff
hires for AI/ML, Biotech, Backend
How to cite this page
Alion, "Boltz: key facts", as of Nov 13, 2026. https://alion.io/company/boltz
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0